Gabriela Zuleger

5PUBLICATIONS
40CO-AUTHORS
Tumour immunologyMechanobiologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 02, 2025
Tempered signal strength via low-dose MEK inhibition optimizes therapeutic performance of engineered T cells.

Franziska Füchsl, Antonia Schwanzer, Melanie Faber

|Mar 16, 2024
Author Correction: Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification.

Celina Tretter, Niklas de Andrade Krätzig, Matteo Pecoraro

|Aug 02, 2023
Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification.

Celina Tretter, Niklas de Andrade Krätzig, Matteo Pecoraro

Pageof 1